Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    



Vanderbilt Team's Discovery Offers New Insight on Lung Cancer Risk


 

Researchers in the Schools of Medicine and Engineering at Vanderbilt University have discovered a proteomic "signature" from the airways of heavy smokers that could lead to better risk assessment and perhaps new ways to stop lung cancer before it starts.

Their findings, reported recently in the journal JCI Insight, are based on the observation that otherwise normal-looking cells in the epithelial lining of the lungs of heavy smokers and others at high risk for lung cancer undergo the same kind of "metabolic reprogramming" as do cancer cells.

To produce the extra lipids, nucleotides and amino acids they need to proliferate rapidly, cancer cells have to consume a lot of fuel, namely glucose. They essentially reverse the normal glucose-production cycle and "reprogram" their metabolism to increase uptake of glucose as well as glutamine, another quick-energy fuel.

The researchers discovered that normal cells in the lungs of heavy smokers do the same thing. The next step is to confirm that metabolic reprogramming is a "prerequisite for uncontrolled growth," said Jamshedur Rahman, PhD, research assistant professor of Medicine.

If so, metabolic reprogramming "would be a biomarker for risk," as well as an avenue for prevention, by targeting enzymes in metabolic pathways that lead to cancer, said senior author Pierre Massion, MD, Cornelius Vanderbilt Professor of Medicine and Cancer Biology.

"We're far from that target," said Massion, who directs the Cancer Early Detection and Prevention Initiative in the Vanderbilt-Ingram Cancer Center (VICC). "But this is a really exciting time for us."

Massion said the research could not have been done without major support from the National Cancer Institute (grant number CA152662) or the contributions of scientists across the University, including the paper's first authors, Rahman and research fellow Xiangming Ji, PhD.

Daniel Liebler, PhD, Ingram Professor of Cancer Research and director of the Jim Ayers Institute for Precancer Detection and Diagnosis at VICC, helped determine the "proteome," the unique set of proteins expressed in the lungs of cancer patients and those at high-risk for developing the disease.

Jamey Young, PhD, associate professor of Chemical and Biomolecular Engineering, developed software that enabled the researchers to track how glutamine was being used by epithelial cells.

Despite decades of attempts to thwart it, lung cancer remains the No. 1 cancer killer in the world, said Massion, who chairs the Lung Cancer Cooperative Group in the Early Detection Research Network, part of the National Cancer Institute.

"It's hard to stop a train that's going 200 miles an hour," he said. "We want to prevent this from gaining speed and, if possible, to ever get on the track."

 
Share:

Related Articles:


Recent Articles

Increasing Number Of Tennesseans Dying From Drug Overdoses

Tennessee Department of Health data show 1,631 Tennesseans died from drug overdoses in 2016, the highest annual number of such deaths recorded in state history. This is an increase from the 1,451 overdose deaths recorded among Tennessee residents in 2015.

Read More

AMA Urges Congress to Take Swift Action to Retain DACA Program Protections

The American Medical Association sent a letter to Congress on Sept. 5 outlining why DACA is an American healthcare issue and urging legislators to take prompt action to ensure individuals with Deferred Action for Childhood Arrivals status are able to remain in the United States.

Read More

New Antiviral Drug Inhibits Epidemic SARS, MERS & More

A multi-institutional team of researchers has found a new antiviral drug candidate that could treat or prevent a number of potential pandemic outbreaks.

Read More

Disaster Preparedness: Are We Ready?

In a world of ever-evolving threats, the officials responsible for a community's health and safety must constantly update, evaluate, prepare and communicate their preparedness plan.

Read More

Addressing Opioid Addiction in America

Even as the AMA works with physicians and other providers to address opioid addiction, the national epidemic continues to evolve.

Read More

Moving Forward on Health Reform

THA's Craig Becker shares the hospital perspective on healthcare reform and what's needed to maintain access to care across Tennessee.

Read More

MGMA Releases 2017 Regulatory Burden Survey: MIPS Tops the List

The results of the Medical Group Management Association (MGMA) 2017 Regulatory Burden Survey reveal there is no shortage of opportunity to reduce regulatory burdens on physician practices.

Read More

In Case of Emergency

On Sept. 8, 2016 the final rule Emergency Preparedness Requirements for Medicare and Medicaid Participating Providers and Suppliers was published in the Federal Register. By Nov. 16, 2017, providers and suppliers must be in compliance.

Read More

Innovative Meharry Program Helps Mothers with Opioid Addiction

The Rainbow Program at Meharry offers pregnant and postpartum women with substance abuse disorders new hope.

Read More

The Osher Center: Healing Mind, Body & Spirit

Multi-faceted approach to pain management blends old and new therapies at The Osher Center for Integrative Medicine at Vanderbilt

Read More

Email Print
 
 

 

 


Tags:
Jamshedur Rahman, Jim Ayers Institute for Precancer Detection and Diagnosis at VICC, lung cancer risk, Pierre Massion, Vanderbilt University
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: